Takashi Oshima

5.9k total citations
270 papers, 3.6k citations indexed

About

Takashi Oshima is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Takashi Oshima has authored 270 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Pulmonary and Respiratory Medicine, 127 papers in Surgery and 122 papers in Oncology. Recurrent topics in Takashi Oshima's work include Gastric Cancer Management and Outcomes (130 papers), Esophageal Cancer Research and Treatment (57 papers) and Metastasis and carcinoma case studies (51 papers). Takashi Oshima is often cited by papers focused on Gastric Cancer Management and Outcomes (130 papers), Esophageal Cancer Research and Treatment (57 papers) and Metastasis and carcinoma case studies (51 papers). Takashi Oshima collaborates with scholars based in Japan, United States and United Kingdom. Takashi Oshima's co-authors include Yasushi Rino, Munetaka Masuda, Chikara Kunisaki, Toru Aoyama, ITARU HASHIMOTO, Takaki Yoshikawa, Tsutomu Sato, Norio Yukawa, Hirochika Makino and Takanobu Yamada and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Takashi Oshima

243 papers receiving 3.6k citations

Peers

Takashi Oshima
Takashi Oshima
Citations per year, relative to Takashi Oshima Takashi Oshima (= 1×) peers Matthias Anthuber

Countries citing papers authored by Takashi Oshima

Since Specialization
Citations

This map shows the geographic impact of Takashi Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Oshima more than expected).

Fields of papers citing papers by Takashi Oshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Oshima. The network helps show where Takashi Oshima may publish in the future.

Co-authorship network of co-authors of Takashi Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Oshima. A scholar is included among the top collaborators of Takashi Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Oshima. Takashi Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagasawa, Shinsuke, Hiroki Akiyama, ITARU HASHIMOTO, et al.. (2024). Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal Gastrectomy. In Vivo. 38(6). 2897–2903.
2.
Kanda, Mitsuro, Chie Tanaka, Kazunari Misawa, et al.. (2024). A multi‐institutional prospective observational study to compare postoperative quality of life of patients who undergo total or proximal gastrectomy for early gastric cancer (CCOG1602). World Journal of Surgery. 48(3). 681–691. 2 indexed citations
3.
HASHIMOTO, ITARU, Shinsuke Nagasawa, Yukio Maezawa, et al.. (2024). A propensity‑matched analysis of the prognostic value of advanced lung cancer inflammation index in patients with gastric cancer after curative resection. Oncology Letters. 27(6). 285–285. 2 indexed citations
5.
HASHIMOTO, ITARU, Shinsuke Nagasawa, Yukio Maezawa, et al.. (2024). Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer. In Vivo. 38(2). 911–916. 10 indexed citations
6.
Shitara, Kohei, Yung‐Jue Bang, Lucjan Wyrwicz, et al.. (2024). Neoadjuvant/adjuvant pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585.. Journal of Clinical Oncology. 42(16_suppl). 4073–4073. 2 indexed citations
7.
Kawazoe, Akihito, Noboru Yamamoto, Hisato Kawakami, et al.. (2024). Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical Cancer Research. 30(7). 1264–1272. 3 indexed citations
8.
Sato, Shinya, Takashi Hama, Kunihiko Hayashi, et al.. (2023). 1562P Claudin 18.2 expression in resected gastric cancer. Annals of Oncology. 34. S874–S874. 3 indexed citations
9.
Hayashi, Kei, ITARU HASHIMOTO, Shinsuke Nagasawa, et al.. (2023). Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer. Anticancer Research. 43(6). 2831–2840.
10.
KOMORI, KEISUKE, Kazuki Kano, Yukio Maezawa, et al.. (2023). Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer. Anticancer Research. 43(6). 2865–2871.
11.
Kawazoe, Akihito, Kensei Yamaguchi, Tsuyoshi Hamaguchi, et al.. (2023). 1546P Safety, efficacy, and biomarkers for ONO-4578 plus nivolumab in unresectable advanced or recurrent gastric or gastroesophageal cancer. Annals of Oncology. 34. S867–S867. 1 indexed citations
12.
Shitara, Kohei, Kensei Yamaguchi, Kei Muro, et al.. (2023). Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study. International Journal of Clinical Oncology. 29(1). 27–35. 2 indexed citations
13.
Hasegawa, Shinichi, Tsutomu Hayashi, Takanobu Yamada, et al.. (2022). Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?. European Journal of Surgical Oncology. 49(1). 76–82.
14.
Saito, Yuichi, Takaki Yoshikawa, Takashi Oshima, et al.. (2021). Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma. British journal of surgery. 109(3). 291–297. 4 indexed citations
15.
Atsumi, Shinichiro, Hiroto Katoh, Daisuke Komura, et al.. (2020). Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases. Communications Biology. 3(1). 588–588. 5 indexed citations
16.
Hara, Kentaro, Tsutomu Hayashi, Shinsuke Nagasawa, et al.. (2019). An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux‐en‐Y reconstruction. Asian Journal of Endoscopic Surgery. 13(2). 238–241. 3 indexed citations
17.
Hiroshima, Yukihiko, Rika Kasajima, Yayoi Kimura, et al.. (2019). Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters. 469. 217–227. 18 indexed citations
18.
Segami, Kenki, Tsutomu Sato, Taiichi Kawabe, et al.. (2015). [A Case of HER-2 Positive Advanced Gastric Cancer Responding to Capecitabine+Cisplatin+Trastuzumab Chemotherapy].. PubMed. 42(10). 1295–7. 1 indexed citations
19.
Kanazawa, Amane, Manabu Shiozawa, Shuzo Tamura, et al.. (2010). Clinicopathological Characteristics and Surgical Outcomes of Mucinous Colorectal Carcinoma with Curative Resection. Nihon Daicho Komonbyo Gakkai Zasshi. 63(2). 43–50. 1 indexed citations
20.
Kanazawa, Amane, Takashi Oshima, Naoto Yamamoto, et al.. (2009). Deviced Reconstruction after Segmental Resection of the Duodenum for Leiomyoma of the Duodenum. The Japanese Journal of Gastroenterological Surgery. 42(5). 499–504.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026